Tiziana Life Sciences (TLSA) Share-based Compensation (2017 - 2025)

Tiziana Life Sciences (TLSA) has reported Share-based Compensation for 8 consecutive years, with $8.2 million the latest figure, recorded in Q2 2025.

• Quarterly Share-based Compensation rose 7.2% year-over-year to $8.2 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $8.2 million (up 7.2% YoY) and the FY2025 annual result came in at $1.9 million, down 74.46% from the prior year.
• Share-based Compensation grew to $8.2 million in Q2 2025 per TLSA's latest filing, from $7.6 million in the prior quarter.
• Over the last five years, Share-based Compensation for TLSA reached as high as $13.8 million in Q4 2021 and fell as low as $5.2 million in Q4 2022.
• A 5-year average of $8.7 million and a median of $7.7 million in 2024 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2022 — Share-based Compensation slumped 62.38% — and 2023, when it soared 33.04%.
• Year by year, Share-based Compensation stood at $13.8 million in 2021, then sank by 62.38% to $5.2 million in 2022, then surged by 33.04% to $6.9 million in 2023, then rose by 10.44% to $7.6 million in 2024, then grew by 8.16% to $8.2 million in 2025.
• According to Business Quant data, Share-based Compensation over the past three periods registered $8.2 million, $7.6 million, and $7.7 million for Q2 2025, Q4 2024, and Q2 2024 respectively.